ClinicalTrials.gg
Status unknownNCT06371677POL-CICUUpdated Apr 17, 2024

Polish Nationwide Register of Hospitalized Patients in Cardiac Intensive Care Units

An observational study in Shock, Death and Cardiac Intensive Care Unit, sponsored by Medical University of Warsaw. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-17.

Sponsored by Medical University of Warsaw · Observational

The sponsor has not verified this record recently (last verified Apr 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Study summary

Cardiac Intensive Care Units (CICUs) provide care for a diverse patient population. Understanding the clinical characteristics, analysis of treatment modalities, and prognosis of patients hospitalized in the CICU are important to improve cardiovascular care. The purpose of this registry is to determine the demographics, clinical, treatment, and prognosis of patients hospitalized in the Polish CICUs. Data from this multicenter, prospective observational study will provide more robust data to facilitate quantitative characterization of cardiac care in contemporary Polish CICUs and enable the development of infrastructure for clinical trials in CICUs.

02

Conditions studied

  • Shock
  • Death
  • Cardiac Intensive Care Unit
  • Treatment Complication
  • Stroke
  • Multiple Organ Failure
  • Infections
03

In context

Shock

922 studies on the registry are indexed under Shock; 172 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 93 across 355 observational studies indexed under Shock.

Browse Shock studies →

Lead sponsor

Medical University of Warsaw is the lead sponsor of 325 studies on the registry; 87 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All consecutive patients hospitalized at Polish CICUs.

Eligibility criteria

All consecutive patients hospitalized at Polish CICUs.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. All-cause death

    Time frame: 01.10.2024 - 31.03.2025

Secondary outcomes

  1. Shock (cardiogenic/hypovolemic/anaphylactic/septic/neurogenic/obstructive)

    Time frame: 01.10.2024 - 31.03.2025

  2. Treatment-related complications (tamponade, dissection, stroke, embolism, etc.)

    Time frame: 01.10.2024 - 31.03.2025

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06371677
Responsible party
Sponsor
First posted
Apr 17, 2024
Start date
Oct 1, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Mar 31, 2025 (estimated)
Last update
Apr 17, 2024

Study contacts

Robert Kowalik, MD, PhD
Contact
rjkowalik@wp.pl
22 599 19 58 ext. +48
Robert Kowalik, MD, PhD
principal investigator · 1st Department of Cardiology, Medical University of Warsaw
Monika Gawałko, MD, PhD
principal investigator · 1st Department of Cardiology, Medical University of Warsaw

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion